These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 5527647
1. [Clinical trial of N-cyclohexyl-N-methyl(-2-amino-3,5-dibromobenzyl)-ammonium chloride associated with antibiotics in therapy of chronic bronchopneumopathies]. Quilici G, Da Porto R. Clin Ter; 1970 Sep 30; 54(6):495-517. PubMed ID: 5527647 [No Abstract] [Full Text] [Related]
2. [Clinico-experimental studies of the mucolytic action of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride, in oral and parenteral administration, in acute and chronic pneumopathies]. Carnimeo N, Fino E, Maiorano V, Marzullo F. Minerva Med; 1969 Sep 22; 60(76):3557-64. PubMed ID: 5823750 [No Abstract] [Full Text] [Related]
3. [Effects of treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride in oral adminstration on bronchial secretions; cytological findings]. Lenzini L, Barnabè R. Minerva Med; 1969 Sep 22; 60(76):3580-2. PubMed ID: 5823754 [No Abstract] [Full Text] [Related]
4. [Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Brignani F, Cavalli A, Fabbri M, Melica A. Minerva Med; 1969 Sep 19; 60(75):3545-8. PubMed ID: 5344814 [No Abstract] [Full Text] [Related]
5. [Effects of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride on expectoration, respiratory function, hepatic and cardiac function of subjects with chronic bronchopneumopathies]. Scarpa GL, Malavasi A, Dimich D, Giraudi D. Minerva Med; 1969 Sep 22; 60(76):3594-9. PubMed ID: 5823756 [No Abstract] [Full Text] [Related]
6. [On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Trombini V. Minerva Med; 1969 Sep 22; 60(76):3600-3. PubMed ID: 5823757 [No Abstract] [Full Text] [Related]
7. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Ercillo L, Mollica G. Minerva Med; 1969 Sep 22; 60(76):3604-6. PubMed ID: 5823758 [No Abstract] [Full Text] [Related]
8. [Apropos of 27 patients treated with bisolvomycin]. Breuil K. Bord Med; 1971 Sep 22; 4(9):2469-70. PubMed ID: 5123583 [No Abstract] [Full Text] [Related]
10. [Biochemical, pharmacological and clinical observations in connection with the broncho-secretolytic, bisolvon]. Rossini G. Med Monatsschr; 1970 Jun 22; 24(6):270-2. PubMed ID: 5525114 [No Abstract] [Full Text] [Related]
18. [Trial of N.80.BT. in the treatment of bronchoponeumopathies]. Pidoux A, Kalb JC. J Med Lyon; 1972 Mar 20; 53(225):439-41. PubMed ID: 5053495 [No Abstract] [Full Text] [Related]
19. [On the effects of the expectorant N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride on respiratory mechanics]. Hamm J, Hunekohl E. Arzneimittelforschung; 1966 Feb 20; 16(2):209-12. PubMed ID: 6014016 [No Abstract] [Full Text] [Related]